Kynmobi Packung Zur Einleitung Der Behandlung (Apomorphine Hydrochloride Hemihydrate)

Apomorphine Hydrochloride is a dopamine agonist used in the management of Parkinson's disease, specifically to address motor fluctuations.

• OFF episodes in Parkinson's disease: provides rapid relief of sudden worsening of motor symptoms.
• Early morning OFF periods: improves mobility upon waking before the next oral dose of levodopa.
• Sudden OFF episodes: restores motor function within minutes when oral therapy is insufficient.

• Apomorphine Hydrochloride acts as a non‑selective dopamine receptor agonist, stimulating both D1 and D2 receptors in the basal ganglia. This activation bypasses the deficient endogenous dopamine in Parkinson's disease, enhancing motor circuit signaling and quickly improving bradykinesia and rigidity.

Apomorphine may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Vomiting: occasional episodes after dosing.
• Dizziness: sensation of light‑headedness, especially on standing.
• Orthostatic hypotension: drop in blood pressure upon standing.
• Headache: transient cranial discomfort.
• Somnolence: feeling unusually sleepy.

Serious or Rare Side Effects

• Severe hypotension: marked blood‑pressure fall requiring medical attention.
• Syncope: fainting episodes linked to low blood pressure.
• Hallucinations or psychosis: visual or auditory disturbances.
• Impulse control disorders: compulsive gambling, shopping, or eating.
• Pulmonary edema: fluid accumulation in the lungs.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating therapy, clinicians should evaluate several safety aspects.

• Cardiovascular assessment: monitor blood pressure and heart rate for hypotensive episodes.
• MAO‑inhibitor washout: avoid use within 14 days of stopping MAO‑B inhibitors.
• Impulse control screening: observe for emerging compulsive behaviors.
• Hepatic function: use cautiously in patients with severe liver impairment.
• Store at ambient temperature: keep in the original pack, protect from moisture and light.

Apomorphine can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

• MAO‑B inhibitors: risk of hypertensive crisis; concurrent use is contraindicated.
• Dopamine antagonists (e.g., metoclopramide): may diminish apomorphine efficacy.
• Alpha‑adrenergic blockers: additive hypotensive effect leading to severe low blood pressure.

Moderate Interactions (Monitor Closely)

• Antihypertensive agents: may enhance blood‑pressure lowering; monitor vitals.
• SSRIs/SNRIs: possible additive central nervous system effects; observe for dizziness.
• Other dopamine agonists: increased risk of cumulative side effects; adjust dosing as needed.